104 filings
6-K
ASLN
ASLAN Pharmaceuticals Ltd
9 May 24
Aslan Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:10am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
7 May 24
Current report (foreign)
7:41am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
22 Apr 24
Aslan Pharmaceuticals Announces Positive Interim Results from Phase 2 Study of Eblasakimab In Dupilumab-experienced Atopic Dermatitis Patients
8:29am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
19 Apr 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Notice
5:01pm
6-K
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Amendment No. 2 to the Open Market Sale Agreementsm
8:10am
6-K
mpu53i9m a1u
12 Apr 24
Aslan Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:05am
6-K
tqmm71
13 Mar 24
Aslan Pharmaceuticals Announces $5 Million Registered Direct Offering
7:27am
6-K
qzbno0r8n0o5neavzj
11 Mar 24
ASLAN PHARMACEUTICALS PROVIDES TREK-DX STUDY UPDATE AND HIGHLIGHTS potENTIAL of EBLASAKIMAB in DUPILUMAB-EXPERIENCED ATOPIC DERMATITIS PATIENTS
8:03am
6-K
xsaerd jgokuo
24 Jan 24
Current report (foreign)
7:52am
6-K
aqp3g jlw
8 Jan 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
7:02am
6-K
lr9d3g9zytu5f5shjc05
22 Dec 23
Current report (foreign)
4:24pm
6-K
4o8e9l
8 Dec 23
Current report (foreign)
4:42pm
6-K
khmqa87rupj6s2h5
27 Oct 23
Aslan Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:14am
6-K
cwc9x dee
24 Oct 23
Aslan Pharmaceuticals to Co-host Kol Panel Discussion Today on Changes In the Clinical Trial and Treatment Landscape for Atopic Dermatitis
8:32am
6-K
ohqc80q575bs6p2gt1jg
16 Oct 23
Current report (foreign)
6:08am
6-K/A
4j6 pdiaym
18 Aug 23
Current report (foreign) (amended)
7:33am
6-K
3pyp53xkndp
11 Aug 23
Aslan Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
8tfd87j0n 61ai
20 Jul 23
Current report (foreign)
7:55am
6-K
o1yxun2dey202je4
6 Jul 23
Current report (foreign)
8:11am
6-K
z3xkgrfai5ea3c40sok
6 Jul 23
Current report (foreign)
7:59am